HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lars Bergmann Selected Research

Carbidopa (Lodosyn)

1/2022Outcomes Impacting Quality of Life in Advanced Parkinson's Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel.
10/2021DUOGLOBE: One-Year Outcomes in a Real-World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease.
1/2021Concomitant Medication Usage with Levodopa-Carbidopa Intestinal Gel: Results from the COSMOS Study.
1/2021The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review.
10/2020Long-term effectiveness of levodopa-carbidopa intestinal gel on motor and non-motor symptoms in advanced Parkinson's disease: results of the Italian GLORIA patient population.
1/2020Predictors of Response for "Off" Time Improvement With Levodopa-Carbidopa Intestinal Gel Treatment: An Analysis of the GLORIA Registry.
1/2020Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson's Disease Receiving ≥2000 mg Daily Dose of Levodopa.
1/2019Levodopa-Carbidopa Intestinal Gel Monotherapy: GLORIA Registry Demographics, Efficacy, and Safety.
1/2019Levodopa-carbidopa intestinal gel in a subgroup of patients with dyskinesia at baseline from the GLORIA Registry.
1/2018Age/disease duration influence on activities of daily living and quality of life after levodopa-carbidopa intestinal gel in Parkinson's disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lars Bergmann Research Topics

Disease

19Parkinson Disease (Parkinson's Disease)
08/2022 - 03/2015
7Dyskinesias (Dyskinesia)
01/2022 - 01/2019
4Infections
12/2021 - 12/2017
4Sepsis (Septicemia)
12/2020 - 11/2016
3Cytomegalovirus Infections (Inclusion Disease)
12/2021 - 01/2019
3Inflammation (Inflammations)
01/2020 - 01/2019
2Emergence Delirium
01/2022 - 01/2019
2Polyneuropathies (Polyneuropathy)
01/2019 - 12/2017
2Hemorrhage
06/2012 - 07/2007
1Delirium
01/2022
1Glioblastoma (Glioblastoma Multiforme)
01/2022
1Neuroblastoma
01/2022
1Acute Kidney Injury (Acute Renal Failure)
01/2020
1Pain (Aches)
01/2019
1Drug-Related Side Effects and Adverse Reactions
01/2019
1Parkinsonian Disorders (Parkinsonism)
10/2016
1Atrial Fibrillation
02/2016
1Aortic Valve Stenosis (Aortic Stenosis)
05/2013
1Thrombocytopenia (Thrombopenia)
06/2012
1Factor XIII Deficiency
06/2012
1Thrombophilia
06/2012
1Restless Legs Syndrome (Restless Legs)
06/2011
1Cardiomyopathies (Cardiomyopathy)
06/2009
1Myocardial Infarction
07/2007
1Epileptic Syndromes
12/2005
1Epilepsy (Aura)
12/2005

Drug/Important Bio-Agent (IBA)

17Levodopa (L Dopa)FDA LinkGeneric
01/2022 - 03/2015
15Carbidopa (Lodosyn)FDA LinkGeneric
01/2022 - 03/2015
4Aquaporin 5IBA
01/2021 - 01/2019
2levodopa drug combination carbidopa (Nakom)FDA LinkGeneric
10/2021 - 01/2021
2Pharmaceutical PreparationsIBA
12/2017 - 02/2016
1Acetylcholine (Acetylcholine Chloride)FDA Link
01/2022
1Cholinesterases (Cholinesterase)IBA
01/2022
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2022
1AcetylcholinesteraseIBA
01/2022
1ButyrylcholinesteraseIBA
01/2022
1Midazolam (Versed)FDA LinkGeneric
01/2022
1SuspensionsIBA
01/2021
1Proteins (Proteins, Gene)FDA Link
12/2020
1Adenosine Triphosphate (ATP)IBA
12/2020
1Mitochondrial DNA (mtDNA)IBA
12/2020
1NucleotidesIBA
01/2020
1Transcription Factors (Transcription Factor)IBA
12/2019
1CytosineIBA
12/2019
1Propofol (Diprivan)FDA LinkGeneric
01/2019
1Aquaporins (Water Channels)IBA
11/2016
1Adenosine (Adenocard)FDA LinkGeneric
02/2016
1Blood Coagulation Factors (Coagulation Factor)IBA
06/2012
1Heparin (Liquaemin)FDA LinkGeneric
06/2012
1Thromboplastin (Tissue Factor)IBA
06/2012
1ropinirole (Requip)FDA LinkGeneric
06/2011
1Antidepressive Agents (Antidepressants)IBA
06/2011
1Adrenergic Receptors (Adrenergic Receptor)IBA
06/2009
1GTP-Binding Proteins (G-Protein)IBA
06/2009
1Lamotrigine (Lamictal)FDA LinkGeneric
12/2005
1Valproic Acid (Depakote)FDA LinkGeneric
12/2005
1Anticonvulsants (Antiepileptic Drugs)IBA
12/2005
1Carbamazepine (Tegretol)FDA LinkGeneric
12/2005
1lipoarabinomannan (LAM)IBA
12/2005

Therapy/Procedure

8Therapeutics
08/2022 - 07/2007
4Activities of Daily Living (ADL)
01/2022 - 01/2018
3Kidney Transplantation
12/2021 - 01/2019
1Transplantation
01/2020
1Organ Transplantation
01/2019
1Transcatheter Aortic Valve Replacement
05/2013
1Cystectomy
07/2007
1Stents
07/2007
1Catheters
07/2007
1Epidural Anesthesia
07/2007